Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XII.d

Myocarditis (can be fulminant)

Publications

Cesa K, Cunningham C, Harris T, Sunseri W

A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.

Cureus. 2022;14(6):e26366

Song HY, Seo GS

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2022;79(1):31-34

Ali A, Kumaravel Kanagavelu AS, Rahimi A, Mehmood Z, Tariq AB, Das T, Elmdaah A

A Rare Case of Mesalazine-Induced Acute Myocarditis in a 19-Year-Old Female With Ulcerative Colitis.

Cureus. 2021;13(11):e20036

Taha ME, Abdalla A, Al-Khafaji J, Malik S

Mesalamine-Induced Myopericarditis: A Case Report and Literature Review.

Cardiology research. 2019;10(1):59-62

Dias T, Santos A, Santos RM, Carvalho A

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

BMJ case reports. 2019;12(2)

Tagawa M, Nakamura Y, Okura Y, Nanba H, Kishi K, Akashi E, Ochiai Y, Asai Y, Chinushi M

Successful Treatment of Acute Fulminant Eosinophilic Myocarditis in a Patient with Ulcerative Colitis Using Steroid Therapy and Percutaneous Cardiopulmonary Support.

Internal medicine (Tokyo, Japan). 2019;58(8):1111-1118

Okoro KU, Roby MD, Bankole AA

Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis.

Case reports in medicine. 2018;2018:9813893

Park EH, Kim BJ, Huh JK, Jeong EH, Lee SH, Bang KB, Seol JS, Sung JW, Kim BS, Kang JH

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

Journal of cardiovascular ultrasound. 2012;20(3):154-6

Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H

Mesalazine-induced myopericarditis in a patient with ulcerative colitis.

International journal of colorectal disease. 2006;21(2):199-200

Marteau P, Nelet F, Le Lu M, Devaux C

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France.

Alimentary pharmacology & therapeutics. 1996;10(6):949-56

Camus P, Piard F, Ashcroft T, Gal AA, Colby TV

The lung in inflammatory bowel disease.

Medicine. 1993;72(3):151-83

Ariza A, López MD, Mate JL, Curós A, Villagrasa M, Navas-Palacios JJ

Giant cell myocarditis: monocytic immunophenotype of giant cells in a case associated with ulcerative colitis.

Human pathology. 1995;26(1):121-3

Kristensen KS, Høegholm A, Bohr L, Friis S

Fatal myocarditis associated with mesalazine.

Lancet (London, England). 1990;335(8689):605